Portola Pharmaceuticals
PTLA
#5319
Rank
โ‚ฌ1.21 B
Marketcap
15,51ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Portola Pharmaceuticals (PTLA)

Revenue in 2020 (TTM): โ‚ฌ0.10 Billion

According to Portola Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ0.10 Billion. In 2019 the company made a revenue of โ‚ฌ0.10 Billion an increase over the revenue in the year 2018 that were of โ‚ฌ34.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Portola Pharmaceuticals from 2012 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ0.10 B8.44%
2019โ‚ฌ0.10 B190.66%
2018โ‚ฌ34.52 M77.99%
2017โ‚ฌ19.39 M-36.5%
2016โ‚ฌ30.54 M194.15%
2015โ‚ฌ10.38 M25.39%
2014โ‚ฌ8.28 M-8.6%
2013โ‚ฌ9.06 M-85.38%
2012โ‚ฌ61.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ79.27 B 76,144.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ54.01 B 51,849.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.88 B 39,222.42%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ8.65 B 8,228.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.32 B 39,643.50%๐Ÿ‡บ๐Ÿ‡ธ USA